Creative Financial Designs’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Creative Financial Designs’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3	Closed	–	–	1483
2021 Q2	$0	Hold	3	–	–	﹤0.01%	1459
2021 Q1	$0	Sell	3 -8	-73%	-$497	﹤0.01%	1387
2020 Q4	$1K	Hold	11	–	–	﹤0.01%	1219
2020 Q3	$1K	Sell	11 -52	-83%	-$8.69K	﹤0.01%	1194
2020 Q2	$11K	Sell	63 -36	-36%	-$6K	﹤0.01%	742
2020 Q1	$14K	Buy	99 +48	+94%	+$14.7K	0.01%	326
2019 Q4	$17K	Buy	+51	New	+$23.4K	0.01%	348

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

VFA

Values First Advisors Gray, Tennessee $219M AUM 33.35% 1-Year Est. Return

Creative Financial Designs's NBRV Position: Q3 2021 in Review

Creative Financial Designs sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2021, closing a stake of 3 shares.

Creative Financial Designs first reported a position in NBRV in Q4 2019 and held it in 7 quarters. The position peaked at $17K in Q4 2019. 31 funds tracked by Wall St. Rank hold NBRV as of Q3 2021.

Creative Financial Designs reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2021 after selling out during the quarter.
Creative Financial Designs sold 3 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2021.
Creative Financial Designs first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2019 and held it in 7 quarters.
Creative Financial Designs's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $17K in Q4 2019.
31 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2021.

Based on Creative Financial Designs's 13F filing for Q3 2021, filed 8 Oct 2021.